HomeQuestion

What is your preferred management strategy for a patient with hairy cell leukemia requiring treatment who has stage 3 CKD?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

For patients with newly diagnosed unmutated CLL how will you decide between BTKi alone vs Ven/BTKi vs Ven/Obin vs Ven/Obin/Acalabrutinib?

If using the triplet AMPLIFY regimen with ven/acala/obin upfront, what do you then plan to use in 2nd line treatment of CLL?

What induction regimen would you consider for KMT2A-rearranged AML in a young patient with multiple medical co-morbidities who is ineligible for clinical trials?

Does the presence of paraneoplastic pemphigus influence your treatment options in CLL?

Do you check LDH levels for patients with CLL who are asymptomatic and on surveillance?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.